Article
Modulation of novel drug targets in neurotransmitter signalling to eradicate leukaemic stem cells in chronic myeloid leukaemia
2019-01-01
Abstract excerpt
The most significant obstacle in developing a cure for chronic myeloid leukaemia (CML) is the existence of TKI-insensitive leukaemic stem cells (LSCs) in patients with residual disease. Previous transcriptomics analysis pointed to neurotransmitter pathways as being active in LSC and normal haematopoietic stem cells (HSCs), but significantly deregulated between them. It was therefore hypothesised that these pathway...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 693d029f-4326-5d5b-956e-079a2ac20e5a
- DOI
- 10.5525/gla.thesis.79052
